In Brief
Haselmann et al. explore molecular mechanisms of autoimmune encephalitis with autoantibodies to the AMPA receptor. Human anti-GluA2 autoantibodies induce internalization of AMPA receptors followed by synaptic scaling-like changes leading to defective synaptic transmission and plasticity resulting in memory dysfunction.
INTRODUCTION
Autoimmune encephalitis represents a heterogeneous group of autoimmune disorders in the CNS that are characterized by autoantibodies (ABs) to neuronal targets localized at central synapses, such as ionotropic or G-protein-coupled receptors, presynaptic proteins, or ion channels (Dalmau et al., 2017) . a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) have been described as targets for autoantibodies in patients with a subtype of autoimmune encephalitis, who may harbor autoantibodies against either the GluA1 or GluA2 or against both subunits of the AMPAR (Gleichman et al., 2014; Lai et al., 2009; Peng et al., 2015) . Patients showing high titers of anti-AMPAR autoantibodies in their cerebrospinal fluid (CSF) most often develop a syndrome of limbic encephalitis with dramatic impairment of the ability to build new memories in addition to temporally graded retrograde amnesia, anxiety, mood changes, psychosis, and temporal lobe seizures (Hö ftberger et al., 2015; Lai et al., 2009) . Besides therapy of the malignant tumor in paraneoplastic cases, patients with AMPAR encephalitis have been treated effectively with plasma exchange and/or immunosuppressive therapy (Dalmau and Graus, 2018; Hö ftberger et al., 2015; Lai et al., 2009) .
First in vitro experimental studies indicate that patient CSF containing AMPAR autoantibodies to both GluA1 and GluA2 subunits decreases synaptic AMPAR clusters and miniature excitatory postsynaptic current (mEPSC) amplitude and frequency in cultures of primary hippocampal neurons without changing expression and function of NMDA receptors (NMDARs) (Lai et al., 2009; Peng et al., 2015) . However, the precise molecular mechanisms and the direct consequences of AMPAR autoantibodies on network plasticity are unknown. Moreover, whether human AMPAR autoantibodies can induce disease symptoms in mice has yet to be shown.
AMPARs are mainly heterotetrameric ionotropic glutamatergic receptors composed of four pore-forming subunits (GluA1 to GluA4) and several auxiliary subunits (Bredt and Nicoll, 2003; Malinow and Malenka, 2002; Schwenk et al., 2012) . The assembly of AMPARs with auxiliary subunits (transmembrane AMPA receptor regulatory proteins, TARPs) regulates many functional properties of the receptor and is crucial for AMPAR trafficking and their anchoring at synapses (Bats et al., 2007; Jackson and Nicoll, 2011) . In normal hippocampus, the majority of synaptic AMPARs are assembled as heteromeric receptors of GluA1 and GluA2 subunits and to a much lesser extent of GluA2 and GluA3 subunits (Greger et al., 2017; Wenthold et al., 1996) . Importantly, the presence of the GluA2 subunit in the AMPAR complex confers different properties to the receptors, which have consequences on AMPAR function in synaptic transmission and plasticity. AMPARs containing GluA2 subunits conduct Na + and K + but not Ca 2+ , whereas those lacking GluA2 are also permeable to Ca 2+ ions, have a large single-channel conductance, and are inwardly rectifying due to a channel block by intracellular polyamines at positive membrane potentials (Bowie and Mayer, 1995; Isaac et al., 2007) . Ca 2+ permeable AMPARs can primarily be found at extrasynaptic sites. During synaptic long-term potentiation (LTP) highly mobile extrasynaptic AMPARs and Ca 2+ permeable AMPARs are incorporated into synapses where they increase Ca 2+ influx and strengthen synaptic transmission (Ehlers et al., 2007; Malinow and Malenka, 2002; Newpher and Ehlers, 2008; Penn et al., 2017; Tardin et al., 2003) . Similarly, after long-lasting decreases in synaptic activity Ca 2+ permeable AMPARs are incorporated at synapses thereby restoring synaptic function, a phenomenon termed homeostatic plasticity by synaptic scaling (Hou et al., 2008; Turrigiano and Nelson, 2004) .
We sought to investigate whether autoimmune mechanisms involving autoantibodies specifically targeting GluA2 influence basic properties of AMPAR function and whether these processes are sufficient to induce characteristic disease symptoms of AMPAR encephalitis. Using purified patient immunoglobulin G (IgG) autoantibodies specifically directed against the GluA2 subunit, we show that anti-GluA2 autoantibodies lead to distinct changes in synaptic transmission by modifications in AMPAR composition and localization, TARP association, and by synaptic scaling-like mechanisms involving enhanced synaptic incorporation of inwardly rectifying, non-GluA2-containing AMPARs. These changes affect LTP in the hippocampus and induce characteristic behavioral changes in vivo. Our results thus identify a unique immuneneuronal interaction that may underlie characteristic disease symptoms.
RESULTS

Human Autoantibodies against GluA2 Induce Synaptic Insertion of Inward Rectifying AMPA Receptors Lacking GluA2
In this study, we used purified IgG fractions from plasma exchange material or serum samples of nine patients with autoimmune encephalitis and high-titer autoantibodies against only the GluA2 subunit of the AMPAR (a-GluA2 IgG) and of a control patient without detectable antineuronal autoantibodies (ct IgG). One IgG fraction was derived from an individual patient with very high titers of specific autoantibodies to GluA2, and the other IgG fraction was derived from a group of eight patients (a-GluA2 IgG 1 and 2, respectively). According to previous reports, all patients presented with limbic encephalitis including severe memory dysfunction and seizures (Hö ftberger et al., 2015; Lai et al., 2009) . We tested the specificity of both purified IgG fractions and found exclusive plasma membrane binding of patient IgG on non-permeabilized GluA2:eGFP but not GluA1:eGFP transfected human embryonic kidney 293 (HEK293) cells and on dissociated neurons. Patient IgG bound to the neuropil in the hippocampus of wild-type (WT), but not in GluA2-knockout (KO) mice. Furthermore, affinity purification experiments with patient IgG in rat brain tissue combined with mass spectrometric analysis confirmed GluA2 as its main target ( Figure S1 ). Thus, patient IgG fractions used in this study target the GluA2 subunit of the AMPAR at high specificity.
We first investigated the effect of a-GluA2 IgG on quantal AMPAR signaling by recording AMPAR-mediated mEPSCs in dissociated hippocampal neurons after 24-hr preincubation with the purified IgG fractions. At a holding potential of À80 mV, mEPSC peak amplitudes were not significantly different between control preparations and a-GluA2 IgGtreated preparations ( Figures 1A-1C ). Rise and decay time were also unchanged in all groups (data not shown). At this holding potential, AMPARs of all subunit compositions contribute to the recorded miniature current. To selectively record currents from AMPARs containing the GluA2 subunit (non-inwardly rectifying AMPARs), neurons were voltage clamped at a membrane potential of +40 mV. Under this condition, mEPSC amplitudes were decreased in neurons treated with a-GluA2 IgG fractions (ct IgG 21.0 ± 1.4 pA, a-GluA2 IgG 1 12.5 ± 0.5 pA, a-GluA2 IgG 2 14.7 ± 0.7 pA), and cumulative probability was shifted toward smaller amplitudes ( Figures 1A, 1B, and 1D ). Under both conditions, the mEPSC frequency was reduced in a-GluA2 IgG-incubated neurons and the cumulative probability plots of inter-event intervals were shifted to greater values ( Figures 1C and 1D) . These findings, obtained in two independent a-GluA2 IgG samples, led us to hypothesize that a-GluA2 IgG results in a decrease of GluA2containing AMPARs and homeostatic incorporation of non-GluA2 AMPARs.
To verify whether these changes were indeed induced by autoantibodies against GluA2, we additionally used the patients' IgG fraction (a-GluA2 IgG 1) depleted of autoantibodies against GluA2 (Figures S1B and S1C) and found no such alterations of mEPSC peak amplitude and frequency at a membrane potential of +40 mV ( Figure S2A ). To test our hypothesis of reduced signaling derived from GluA2-containing AMPARs and homeostatic incorporation of non-GluA2 AMPARs, we used two complementary approaches: First, 1-naphthyl acetyl spermine (NASPM), a selective blocker of AMPARs lacking GluA2 (Koike et al., 1997) led to a significant reduction of the mEPSC peak amplitude in neurons held at À80 mV that had been preincubated with a-GluA2 IgG (Figures 1E and 1F) . In contrast, NASPM did not significantly alter mEPSCs in control IgG-treated neurons (Figure S2B) . Second, inhibition of synaptic scaling-like mechanisms of postsynaptic accumulation of AMPARs by blockade of the ryanodine receptor preventing mobilization of intracellular Ca 2+ sources (Vlachos et al., 2013) led to a significant reduction of mEPSC peak amplitude ( Figures 1G and 1H) . These findings suggest that the unaltered mEPSC amplitude at À80 mV after preincubation with a-GluA2 IgG (cf. Figure 1C ) is mediated by compensatory synaptic incorporation of AMPARs lacking GluA2.
Antibodies against GluA2 Lead to Decrease of Iontophoretically Evoked AMPA-Receptor-Mediated EPSCs on the Multisynaptic but Not on the Single-Synapse Level To dissect pre-and postsynaptic mechanisms that might contribute to the observed changes in mEPSC amplitude and frequency, we performed iontophoretic application of L-glutamate to individual synapses of primary neurons. Depending on the stimulation strength, this procedure allows both stimulation of single synapses and multi-synaptic stimulation of larger dendritic portions (Figures 2A, 2B , and S3). Single-synapse stimulation revealed unchanged iontophoretically evoked AMPARmediated EPSCs (ieEPSCs) at À80 mV after long-time pre-incubation with a-GluA2 IgG over 24 hr consistent with the analysis of the mEPSC amplitude (cf. Figure 1C ). However, we found reduced ieEPSC amplitudes at increased stimulation strength when a multi-synaptic response was elicited (Figures 2B and 2C) . These findings provide an explanation for the reduced frequency of spontaneous events, as they indicate a decrease in the number of functional glutamatergic synapses.
When we performed paired-pulse stimulation of individual synapses, we found rapid desensitization and prolonged monoexponential recovery from desensitization. Preincubation with a-GluA2 IgG slowed the recovery from desensitization in the paired-pulse paradigm ( Figure 2D ) similarly to findings in neurons from GluA2-KO mice (Harvey et al., 2001) or in HEK293 cells with homomeric GluA1 receptors after transfection with only the GluA1 subunit (Grosskreutz et al., 2003) consistent with a rearrangement of AMPAR subunit composition from GluA2 to GluA1.
GluA2 but Not GluA1 Subunits Are Reduced in Synapses
To directly test the hypothesis of synaptic AMPAR rearrangement, we analyzed the structural changes of synaptic AMPAR subunit expression in dissociated hippocampal neurons by confocal and direct stochastic optical reconstruction microscopy (dSTORM). When we quantified the total dendritic postsynaptic spots as revealed by analysis of Homer1 regions, we found that after 24-hr incubation with a-GluA2 IgG the mean areas of Homer1 clusters were unchanged and the number of Homer1 density regions per dendrite length was slightly reduced (Figures 3A, 3B, and S4) . Importantly, as revealed by confocal and superresolution microscopy, the amount of synaptic GluA2 localizations within the Homer1-defined regions was decreased after a-GluA2 IgG preincubation ( Figures 3C-3H ). In extrasynaptic regions, GluA2 localizations were not significantly reduced. However, due to less well-defined dendritic boundaries and background fluorescence in larger areas, quantification in these (A) Example traces showing mEPSCs from individual neurons preincubated 24 hr with ct IgG, a-GluA2 IgG 1, and a-GluA2 IgG 2 at holding potential À80 (left) and +40 mV (right). (B) Averaged single mEPSC traces from individual neurons preincubated 24 hr with ct IgG, a-GluA2 IgG 1, and a-GluA2 IgG 2 at holding potential À80 and +40 mV. (C) Mean mEPSC amplitudes at À80 mV are not different upon a-GluA2 IgG treatment, whereas mEPSC frequency is reduced for a-GluA2 IgG 1 (ct versus a-GluA2 1 p = 0.024) and interevent intervals are increased for both a-GluA2 IgGs (ct versus a-GluA2 1 p < 0.001; ct versus a-GluA2 2 p < 0.001); n (ct IgG) = 15, n (a-GluA2 IgG 1) = 16, n (a-GluA2 IgG 2) = 15 for all bar graphs, n (ct IgG) = 450, n (a-GluA2 IgG 1) = 450, n (a-GluA2 IgG 2) = 450 for cumulative probability plots with 30 randomly chosen mEPSCs per neuron. (D) At depolarized membrane potential (+40 mV) mean mEPSC amplitudes (ct IgG versus a-GluA2 IgG 1 p < 0.001; ct IgG versus a-GluA2 IgG 2 p = 0.006) and frequencies (ct IgG versus a-GluA2 IgG 1 p = 0.012; ct IgG versus a-GluA2 IgG 2 p = 0.044) are reduced in neurons preincubated with a-GluA2 IgG. Cumulative probability plots show an increased proportion of small amplitudes (ct versus GluA2 IgG 1 and 2 p < 0.001) and longer interevent intervals in a-GluA2-IgG-treated neurons (ct versus GluA2 IgG 1 and 2 p < 0.001); n (ct IgG) = 15, n (a-GluA2 IgG 1) = 16, n (a-GluA2 IgG 2) = 15 for all bar graphs, n (ct IgG) = 450, n (a-GluA2 IgG 1) = 450, n (a-GluA2 IgG 2) = 450 for cumulative probability plots with 30 randomly chosen mEPSCs per neuron. (E) Example traces showing mEPSCs from individual neurons preincubated 24 hr with a-GluA2 IgG 1 or a-GluA2 IgG 1 + NASPM. (F) In an independent experimental series, block of non-GluA2-containing receptors by NASPM leads to a decrease of mean mEPSC amplitudes at membrane potential of À80 mV in a-GluA2 IgG 1-incubated neurons (blue) as compared to a-GluA2 IgG 1 incubation alone (red). A cumulative probability plot of mEPSCs shows an increased proportion of small amplitudes in a-GluA2 IgG 1 + NASPM-treated neurons (p < 0.001). Mean frequency of a-GluA2 IgG 1 and NASPM-incubated neurons is not significantly different (p = 0.070) similar as cumulative probability of mEPSC interevent intervals (p = 0.15); n (a-GluA2 IgG 1) = 15, n (a-GluA2 IgG 1 + NASPM) = 14, n (a-GluA2 IgG 1) = 420, n (a-GluA2 IgG 1 + NASPM) = 420 for cumulative probability plots with 30 randomly chosen mEPSCs per neuron. (G) Example traces showing mEPSCs from individual neurons treated for 2-3 days with ryanodine and preincubated 24 hr with ct IgG or a-GluA2 IgG 1. (H) Preincubation with a-GluA2 IgG 1 in neurons after blockade of the ryanodine receptor leads to a reduction of mEPSC amplitudes (ct IgG + ryanodine versus a-GluA2 IgG 1 + ryanodine p = 0.02) and frequency (p = 0.02) at À80 mV membrane potential. Cumulative probability plots show an increase of smaller amplitudes (ct IgG + ryanodine versus a-GluA2 IgG 1 + ryanodine, p < 0.001) and longer interevent intervals (p = 0.003); n (ct IgG + ryanodine) = 21, n (a-GluA2 IgG 1 + ryanodine) = 20 for all bar graphs; n (ct IgG + ryanodine) = 600, n (a-GluA2 IgG 1 + ryanodine) = 480 for cumulative probability plots with 30 randomly chosen mEPSCs per neuron. Comparisons were performed using ANOVA on Ranks with Dunn's post hoc correction for group comparisons and the Mann-Whitney U test for comparison of two groups. Kolmogorov-Smirnov-test was used for cumulative probability plots. Data for bar graphs are presented as mean ± SEM. See also Figure S2 . areas may be carefully interpreted ( Figure S4A ). Distance analysis of AMPAR subunits with respect to the synaptic Homer region corroborated the decreased GluA2 receptor localizations within the $500-nm vicinity that may also include perisynaptic regions ( Figure S4D ). As synaptic AMPAR in the hippocampus regularly exist as GluA1/2 heterodimers (Henley and Wilkinson, 2016; Lu et al., 2009 ), a similar reduction of GluA1 subunit expression would be expected following autoantibody-induced AMPAR internalization. However, synaptic GluA1 density and the perisynaptic amount of GluA1 were unchanged ( Figures 3C-3H ). Thus, in line with our functional experiments in primary neurons, these findings demonstrate autoantibody-induced depletion of heteromeric synaptic AMPARs containing GluA2 most likely followed by a synaptic incorporation of GluA1 homomeric AMPARs.
Early Effects of Antibodies against GluA2
In addition to the effects of synaptic AMPAR rearrangement, specific autoantibodies to GluA2 may also affect AMPAR ion channel function directly or may interfere with AMPAR association with TARPs that control anchoring of highly mobile AMPARs at the postsynaptic density (Bats et al., 2007) . To investigate acute effects of patients' IgG fractions, we applied ct IgG or a-GluA2 IgG to tSA201 cells transfected with GluA1/GluA2 heterodimers only. Short IgG application did not induce changes of glutamate-evoked inward currents thus arguing against direct effects on AMPAR ion channel function ( Figure 4A ). Next, we tested whether patients' IgG modifies the interaction of AMPAR and stargazin, the prototypical TARP co-expressed with AMPAR. Therefore, we performed fast application of glutamate onto outside-out patches from tSA201 cells that were cotransfected with GluA1/GluA2 heterodimers and stargazin 25 ± 3 min after 4-min preincubation of the cells with a-GluA2 IgG or ct IgG. Rectification index (peak current at +60 mV/-60 mV) was 0.91 ± 0.02 for ct IgG versus 0.89 ± 0.03 for a-GluA2-IgG indicating about 90% of heterodimeric AMPAR in both experimental groups. Non-stationary fluctuation analysis (NSFA) in these patches of defined AMPAR composition revealed reduced single-channel conductance ( Figure 4B ). Since stargazin increases AMPAR single-channel conductance (Jackson and Nicoll, 2011) , these findings suggest dissociation of TARPs in cells incubated with pathogenic autoantibodies at this early time point. To test this hypothesis, we used tSA201 cells transfected with GluA1 and a tandem protein in which GluA2 is fused to stargazin by a 9-amino-acid (aa) linker (GluA2:stargazin). NSFA experiments resulted in single-channel conductance that was unchanged after 4-min treatment with a-GluA2-IgG (Figure 4C) , thus corroborating the hypothesis of IgG-induced AMPAR-TARP dissociation in the non-fused constructs.
We next evaluated the effect of short-duration incubation of patients' IgG fractions on synaptic mEPSCs in primary neurons at À80 mV. Short-duration application (mean duration of IgG application: 25 ± 2 min) did not affect mEPSC peak amplitude, kinetics, and frequency. However, longer duration of autoantibody incubation (59 ± 4 min) led to reduction of mEPSC frequency (ct IgG 2.2 ± 0.6 Hz, a-GluA2 IgG 1 1.0 ± 0.2 Hz) with unchanged mEPSC amplitudes indicating similar regulation at that time point as observed in the experiments with 24-hr incubation after compensatory incorporation of non-GluA2-containing AMPARs ( Figures 4D and 4E ). These initial changes may be explained by antibody-induced receptor mobilization from the postsynaptic density at early time points that is followed by internalization at perisynaptic localized endocytic zones (Rosendale et al., 2017) .
Antibody-Induced Endocytosis of GluA2
Previous studies provided evidence of reduced surface AMPAR expression upon challenge with pathogenic patient IgG antibodies (Lai et al., 2009 ). Using super-resolution dSTORM, we here demonstrate that patients' a-GluA2 IgG reacts with synaptic and extrasynaptic located GluA2 subunits (Figures 5A and 5B) similar to previous reports using commercial AMPAR antibodies (Nair et al., 2013) . To test the hypothesis of antibody-induced receptor internalization with a complementary approach, we performed sequential staining to determine membrane-bound and internalized GluA2 AMPARs. We found reduced surface expression of GluA2 upon pretreatment with patients' a-GluA2 (C) In hippocampal neurons with a-GluA2 IgG preincubation ieEPSC peak amplitudes are unchanged after single synapse stimulation (100-nA eject current) but are severely decreased after multisynaptic stimulation (750-nA eject current; n (ct IgG) = 18, n (a-GluA2 IgG) = 12; p = 0.004, Mann-Whitney U test). (D) Paired-pulse stimulation is performed at the indicated inter-pulse intervals (IPIs) with a 750-nA eject current. In neurons with GluA2 autoantibodies, recovery from desensitization is prolonged as compared to controls (n (ct IgG) = 16, n (a-GluA2 IgG) = 14; p < 0.001, two-way-ANOVA with Holm-Sidak post hoc analysis). Recovery after desensitization was fitted by a two exponential equation, and t was determined from the fitted curves as 1/e of recovery. Data are presented as mean ± SEM. See also Figure S3 .
IgG. This effect was reversed when endocytosis was blocked during IgG application ( Figures 5C and 5D ). Together, these data indicate that at an early time point autoantibodies to GluA2 may lead to beginning dissociation of AMPARs and TARPs and disruption of synaptic anchoring, followed by endocytosis of GluA2-containing heteromeric AMPARs and compensatory regulation with synaptic insertion of non-GluA2 AMPARs.
Stereotactic Intrahippocampal Injection of Human a-GluA2 IgG in Mice Induces AMPAR Rearrangement as Observed in Dissociated Hippocampal Neurons
To elucidate the pathogenic mechanisms of GluA2 autoantibodies in the brain, we evaluated AMPAR-mediated synaptic transmission in the hippocampal network after stereotactic intra-hippocampal injection of a-GluA2 IgG fractions in mice in comparison to control IgG and physiological saline (0.9 M).
The amount of injected human IgG detected in mice hippocampi was similar for control and a-GluA2 IgG ( Figure S5A ). Concomitant injection of FM1-43 dye that labels active synapses served as a marker in acute brain slices for verification that IgG fractions were applied to the correct recording site ( Figure 6A ). In some mice, specific binding of injected patient IgG fractions to the AMPAR GluA2 subunit in vivo was confirmed by immunoprecipitation of the bound human IgG that was found exclusively after a-GluA2 IgG injection ( Figure S5B ). Analysis of synaptic spines using Neurolucida reconstructions of CA1 apical dendrites revealed unchanged spine density and morphology in ct IgG and a-GluA2 IgG-injected mice ( Figure S5C ), thus arguing against major changes in structural plasticity or dendritic pruning (B) Homer1 area is unchanged upon preincubation with a-GluA2 IgG (n (ct IgG) = 907 (synapses), n (a-GluR2 IgG) = 1,006 (synapses); p = 0.978). Homer1 positive postsynaptic spots per dendrite length are reduced in presence of a-GluA2 IgG (n (ct-IgG) = 31 [dendrites], n (a-GluR2 IgG) = 37 [dendrites]; p = 0.006, Mann-Whitney U test).
(C) Example confocal stains of GluA2 (upper row; red) or GluA1 (lower row, red) together with Homer1 (green) in primary hippocampal neuron dendrites after preincubation with ct IgG (left) or a-GluA2 IgG (right). Scale bar: 5 mm.
(D) Analysis of confocal stains reveals decreased synaptic GluA2 expression as defined by colabeling with Homer1 upon 24-hr preincubation with a-GluA2 IgG, whereas synaptic GluA1 is unchanged (p = 0.023, unpaired t test).
(E) Extrasynaptic density of GluA1 and GluA2 subunits is unchanged after ct IgG and a-GluA2 IgG preincubation (n (ct IgG) = 10/10 [dendrites], n (a-GluR2 IgG) = 9/10 [dendrites]; for GluA1/GluA2 stains, in D and E). AMPARs. AMPAR-mediated currents are activated by 1 mM glutamate plus 50 mM cyclothiazide. During the steady-state current, a piezo-controlled rapid application of agonists plus a-GluA2 IgG 1 (left) or ct IgG (right) is performed (10-s duration). Cells are clamped at À60 mV during recording, and a 5-s positive test pulse at +60 mV is applied during the activation to test the presence of GluA2 subunits in the AMPARs. The steady-state current in the presence of ct IgG or a-GluA2 IgG 1 is unchanged in comparison with autoantibody-free solution, respectively (I pre / I post = 100.2 ± 0.39 for ct IgG versus 99.30 ± 0.63 for a-GluA2 IgG 1; n (ct IgG) = 9, n (a-GluA2 IgG 1) = 9; p = 0.226, unpaired t test).
(legend continued on next page) after application of a-GluA2 IgG. To investigate AMPAR subunit expression after targeted intrahippocampal injection of purified IgG fractions, we performed confocal analysis of the hippocampal dentate gyrus (DG) and CA1 region. Here, we found synaptic downregulation of GluA2 corroborating the in vitro findings obtained by confocal and super-resolution microscopy ( Figures  S5D-S5F) .
In whole-cell patch-clamp recordings from granule cells (GCs) in the DG, we electrically evoked EPSCs (eEPSCs) by stimulation of the lateral perforant path (LPP). Corroborating our cell-culture findings, we did not find differences in the amplitudes (ct IgG 109.8 ± 13.7 pA, a-GluA2 IgG 112.9 ± 13.8 pA, saline 105.1 ± 9.4 pA) and kinetics (data not shown) of eEPSC between saline, ct IgG, and a-GluA2 IgG-injected mice ( Figures 6B and 6C ). Paired-pulse stimulation induced facilitation in the LPP-DG pathway without differences between the experimental groups ( Figure 6D ). Although facilitation in this pathway is believed to be mainly mediated by presynaptic mechanisms , postsynaptic regulating effects also may contribute to an unchanged paired-pulse ratio as in vitro experiments (B) Non-stationary fluctuation analysis (NSFA) from outside-out patches transfected with GluA1, GluA2, and TARP g2 (stargazin) after rapid application of 10 mM glutamate (26 min after IgG incubation). Examples are shown on the left; insets display average traces with a single response shown in gray. A discontinue line denotes background variance. The single-channel conductances obtained for these two cells are 8.19 pS (for ct IgG) and 5.48 pS (for a-GluA2 IgG). Comparison of single-channel conductance reveals reduction in outside-out patches from cells with a-GluA2 IgG 1 compared with ct IgG (n (ct IgG) = 12, n (a-GluA2 IgG 1) = 12; p = 0.008, unpaired t test). (C) NSFA from outside-out patches transfected with GluA1 and GluA2 fused to TARP g2. Rectification index is 0.96 ± 0.04 for ct IgG and 0.91 ± 0.06 for a-GluA2-IgG. The single-channel conductances for the exemplary cells (left) are 12.90 pS (for ct IgG) and 12.83 pS (for a-GluA2 IgG). Single-channel conductance in both experimental groups is unchanged (right; 11.23 ± 1.22 pS versus 11.26 ± 1.44 pS; n (ct IgG) = 10, n (a-GluA2 IgG 1) = 8; p = 0.99, unpaired t test). (D) Example traces showing mEPSCs from individual neurons preincubated for 25 min (short incubation, left) and for 60 min (right) with ct IgG or a-GluA2 IgG 1. (E) Short-duration preincubation of primary neurons with a-GluA2 IgG 1 (duration 25 ± 2 min) reveals unchanged mEPSC amplitude and frequency at À80 mV membrane potential, whereas longer incubation a-GluA2 IgG 1 (duration 59 ± 2 min) induces a reduction of mEPSC frequency (p = 0.01, Mann-Whitney U test) and longer interevent intervals (p < 0.001, Kolmogorov-Smirnov-test). Short-duration incubation: n (ct IgG) = 9, n (a-GluA2 IgG 1) = 10, for bar graphs, n (ct IgG) = 270, n (a-GluA2 IgG 1) = 300 for cumulative probability plots with 30 randomly chosen mEPSCs per neuron. Long incubation: n (ct IgG) = 8, n (a-GluA2 IgG 1) = 6, for bar graphs, n (ct IgG) = 240, n (a-GluA2 IgG 1) = 180 for cumulative probability plots. Data are presented as mean ± SEM. showed slowed recovery after desensitization (cf. Figure 2D ). When we analyzed large numbers of eEPSCs by peak scaled NSFA, we found a decrease in the average number of channels from 56.4 ± 10.4 after ct IgG and 44.6 ± 4.4 after saline injection to 26.4 ± 2.6 in slices from a-GluA2 IgG-injected mice ( Figure 6E ) and an increase in single-channel conductance from 23.5 ± 3.5 pS in ct IgG and 25.4 ± 3.1 in the saline group to 46.8 ± 5.4 pS in slices from a-GluA2 IgG-injected mice. Similarly to our in vitro findings, mEPSC amplitudes in slices of a-GluA2 IgG-injected mice but not in controls were decreased when slices were superfused with NASPM (a-GluA2 10.1 ± 0.6 pA, a-GluA2 IgG + NASPM 7.9 ± 0.4 pA; Figures Together, these results also indicate that in vivo hippocampal injection of pathogenic a-GluA2 IgG changes AMPAR properties, most likely resembling incorporation of GluA1 homomeric AMPARs. To test this hypothesis more rigorously, we used KO mice lacking the GluA1 subunit (GluA1-KO) (Andrá sfalvy et al., 2003) . In contrast to WT mice, eEPSC amplitude in GluA1-KO mice was reduced upon intrahippocampal injection of a-GluA2 IgG (ct IgG 65.6 ± 8.1 pA, a-GluA2 IgG 42.1 ± 5.5 pA; Figures  6H and 6I ). Facilitation induced by paired-pulse stimulation was unchanged supporting the hypothesis of postsynaptic origin of the observed decline of eEPSC amplitude ( Figure 6J ). Moreover, NSFA revealed a persistent decrease in active channels contributing to eEPSCs (ct IgG 34.9 ± 5.9, a-GluA2 IgG 19.5 ± 3.5; Figure 6K ), but the compensatory increase in sin-gle-channel conductance observed in WT neurons was no longer present. Corroborating these findings, mEPSC amplitudes were decreased in slices of GluA1-KO mice after a-GluA2 IgG injection ( Figure S6E ). These data substantiate the hypothesis of a synaptic scaling-like mechanism in WT neurons induced by increased incorporation of GluA1 AMPARs.
Antibodies against GluA2 Impair Long-Term Synaptic Plasticity in the Schaffer-Collateral-CA1 Pathway Defective memory and cognition are key features of patients suffering from autoimmune encephalitis with autoantibodies to the AMPAR (Lai et al., 2009) . We therefore analyzed synaptic plasticity by measuring LTP in the Schaffer collateral (SC)-CA1 pathway of the hippocampus 24 hr after stereotactic injection of IgG fractions in the CA1 region of the hippocampus ( Figure 7A ). Input-output local field excitatory postsynaptic potential (fEPSP) measurements of basal glutamatergic transmission in the SC-CA1 synapses before potentiation were unchanged corroborating our findings in eEPSC recordings ( Figure 7B ). However, after induction of LTP by theta burst stimulation (TBS), we observed impaired potentiation of fEPSP slope in GluA2 IgG-injected mice as compared to controls ( Figure 7C ). Quantification during the late phase (60-80 min after TBS) revealed strongly reduced slope values in these mice (ct IgG 41.3% ± 9.0%, a-GluA2 16.7% ± 5.8%; Figure 7C ) suggesting heavily impaired synaptic plasticity in the region of a-GluA2 IgG deposition. Paired-pulse facilitation after single stimuli (interstimulus interval (B) Example traces and average of LPP-GC evoked eEPSCs with averaged trace from ct-IgG (gray), a-GluA2 IgG 1 (red), and saline (yellow)-injected mice at resting membrane potential. (C) At resting membrane potential quantitative analysis of eEPSC peak amplitude is unchanged in all experimental groups (n (ct IgG) = 15, n (a-GluA2 IgG) = 17, n (saline) = 22). (D) Paired-pulse facilitation as indicated by the index of the second versus the first pulse (PP ratio) is not different in all experimental groups (n (ct IgG) = 13, n (a-GluA2 IgG) = 15, n (saline) = 21). (E) Non-stationary fluctuation analysis (NSFA) of peak-scaled eEPSCs. Exemplary plot of a-GluA2 (red), ct IgG (black), and saline (gray)-injected animals (30 bins per condition, median ± SD; n (ct IgG) = 137 traces; n (a-GluA2 IgG) = 139; n (saline) = 86). Slope indicating single-channel conductance is increased in recordings of the a-GluA2 IgG-injected mouse, whereas the number of channels is reduced as revealed by the equation of the hyperbola. Quantification of NSFA reveals a decrease of active receptors in a-GluA2 IgG-treated animals (n (ct IgG) = 15, n (a-GluA2 IgG) = 20, n (saline) = 10; p (ct versus a-GluA2) < 0.001, p (saline versus a-GluA2) = 0.004; oneway ANOVA on ranks with Dunn's post hoc correction). NSFA estimated single-channel conductance is increased in a-GluA2 IgG-injected mice (n (ct IgG) = 15, n (a-GluA2 IgG) = 20, n (saline) = 10; p (ct versus a-GluA2) < 0.001, p (saline versus a-GluA2) = 0.034; one-way ANOVA on ranks with Dunn's post hoc correction). (F) Example traces of mEPSC recordings from a-GluA2 IgG-injected brain slices treated with (blue) or without NASPM (red). (G) Mean mEPSC amplitudes and cumulative probability plots at À80 mV of granule cells after a-GluA2-IgG injections before and after perfusion with NASPM. Decreased amplitudes (n (a-GluA2 IgG) = 16, n (a-GluA2 IgG + NASPM) = 16; p = 0.009; t test) and an increased proportion of small amplitudes in the cumulative probability plot after NASPM administration (n (a-GluA2 IgG) = 480, n (a-GluA2 IgG + NASPM) = 480 for cumulative probability plots with 30 randomly chosen mEPSCs per neuron; p < 0.001; Kolmogorov-Smirnov-test) indicate block of AMPARs without GluA2 subunit in brain slices of these mice. mEPSC frequency is unchanged after IgG injections before and after perfusion with NASPM (n (a-GluA2 IgG) = 16, n (a-GluA2 IgG + NASPM) = 16 and n (a-GluA2 IgG) = 480, n (a-GluA2 IgG + NASPM) = 480 for cumulative probability plots with 30 randomly chosen mEPSCs per neuron). (H) Example traces and averages of LPP-GC eEPSCs from slices of GluA1-KO mice injected with ct IgG (gray) and a-GluA2 IgG (red), respectively. (I and J) In GluA1-KO mice eEPSC amplitude is reduced (I) after stereotactic a-GluA2 IgG microinjections (n (ct IgG) = 14, n (a-GluA2 IgG) = 21; p = 0.023; Mann-Whitney U test), whereas paired-pulse facilitation (J) is still unchanged (n (ct IgG) = 6, n (a-GluA2 IgG) = 14). (K) NSFA of peak-scaled eEPSC. Exemplary plot of GluA1-KO hippocampal slices after a-GluA2 IgG (red) and ct IgG (black) IgG injection (30 bins per condition, median ± SD; n (ct IgG) = 112 traces; n (a-GluA2 IgG) = 120). Slope indicating single-channel conductance is unchanged, whereas the number of channels given by the equation of the hyperbola is reduced in recordings of the a-GluA2 IgG-injected mouse. Quantification of NSFA reveals a decrease of active channels in a-GluA2 IgG-treated GluA1-KO mice (n (ct IgG) = 10, n (a-GluA2 IgG) = 10; p = 0.038; Mann-Whitney U test), but single-channel conductance is unchanged (n (ct IgG) = 10, n (a-GluA2 IgG) = 10). Data are presented as mean ± SEM. See also Figures S5 and S6 . 100 ms) was present in both conditions and unchanged before and after LTP induction ( Figure 7D ), thus underlining the postsynaptic nature of LTP impairment. These data demonstrate that stereotactic intrahippocampal microinjection of human a-GluA2 IgG fractions in mice severely impairs LTP in the SC-CA1 pathway.
Mice Develop Memory Deficits and Increased Anxietylike Behavior in Different Passive-Transfer Models Using Human Antibodies to GluA2 Patients with AMPAR encephalitis are characterized by severely affected limbic system with strong memory impairment as a key symptom of disease. To analyze the impact of a-GluA2 autoantibodies in behaving animals, we used two independent passive-transfer animal models: (1) continuous 2-week infusion of IgG fractions or saline into both lateral ventricles (Planagumà et al., 2015) ( Figures 8A and 8B) ; and (2) stereotactic injections of patient IgG directly into the CA1 and CA3 region and the DG of the hippocampus on both sides (Haselmann et al., 2015) ( Figures 8F and 8G ). General locomotor activity and total time spent exploring the objects during the novel object recognition (NOR) test (internal control) was unchanged in animals of all experimental groups and both application procedures (Figures 8C, 8H, and S7 ). However, we consistently found memory impairment as revealed by a decrease of the object recognition index (Figures 8D and 8I) . The experimental setting of chronic intraventricular infusion allowed testing at several time points during and after the infusion period. Here, we found progressive deterioration of memory function with a maximum at day 18 when pump infusion had just stopped a few days before. With longer recovery (day 25), the object recognition had recovered with an index similar to normalized control group levels ( Figure 8D ). When we tested for anxiety-like behavior using an elevated plus maze (EPM) or a black-and-white (BW) maze, we found reduced time spent at and less entries into the open arm or white sector in the groups receiving a-GluA2 IgG, respectively, indicating increased anxiety-like behavior (Figures 8E, 8J , and S7). Thus, our two independent passive-transfer animal models for in vivo application of a-GluA2 autoantibodies induce typical signs of disease in the recipient mice.
DISCUSSION
By combining various electrophysiological and imaging techniques, and in vitro and in vivo analysis including passive-transfer experiments, we here demonstrate that pathogenic human autoantibodies against GluA2 provoke a rearrangement of synaptic AMPARs in mice. This AMPAR rearrangement provides a unique and disease-relevant concept of direct immune-neuronal interaction to explain consequences of encephalitis and the impaired memory formation in the patients. LTP is severely affected after a-GluA2 IgG injection (red) into the hippocampus as compared to ct IgG injection (black; n (ct IgG) = 8, n (a-GluA2 IgG) = 6; p < 0.001; two-way-ANOVA repeated measurements with Holm-Sidak post hoc analysis). Inset shows averaged sample traces of fEPSPs from ct IgG (black) and a-GluA2 IgG-treated slices (red) before and after induction of LTP. Right: quantification of LTP induced changes in the fEPSP slope in the consolidation phase (last 20 min of recording; n (ct IgG) = 8, n (a-GluA2 IgG) = 6; p = 0.013; Mann-Whitney U test).
(D) Short-term plasticity is unchanged after a-GluA2 IgG microinjection as measured by CA1 fEPSP recordings. Paired-pulse stimulation (interstimulus interval 100 ms) was performed in the Schaffer collateral-CA1 pathway before and after induction of LTP by TBS. Paired-pulse facilitation is observed in both experimental groups (ct IgG and a-GluA2 IgG microinjection) before and after TBS (n (ct IgG) = 8, n (a-GluA2 IgG) = 6; paired t test). Note that ct IgG-injected mice
show LTP with increased slope values in comparison of the first stimuli before and after TBS. Against this, slope values of the first stimuli in a-GluA2 IgGinjected mice before and after TBS are not significantly changed corroborating deficits in LTP; see also (C). Data are presented as mean ± SEM.
Synaptic Scaling as a Mechanism in AMPAR Encephalitis
Here, we show that human a-GluA2 autoantibodies provoke a compensatory synaptic insertion of inwardly rectifying, non-GluA2 AMPARs. This conclusion is based on the following findings: first, only those neurons preincubated with anti-GluA2 autoantibodies showed inward rectification and block by endogenous spermine upon depolarization, which are characteristic properties of non-GluA2-containing AMPARs (Verdoorn et al., 1991) . Second, normal mEPSC and single-synapse ieEPSC amplitudes indicate functional compensation that was inhibited by blockade of synaptic scaling-like mechanisms. Third, the slowed recovery from desensitization in dissociated cells indicates receptor rearrangement as AMPARs lacking the GluA2 subunit show in general faster desensitization kinetics (Mosbacher et al., 1994) . Fourth, confocal and super-resolution imaging analysis in primary neurons confirmed loss of synaptic GluA2 subunits only. Fifth, whereas at early time points dissociation of TARPs led to reduced conductance of GluA1/GluA2 heteromers, the single-channel conductance was increased in WT mice 24 hr after intrahippocampal injection of anti-GluA2 autoantibodies consistent with the larger single-channel conductance of GluA1 homomeric AMPARs (Sommer et al., 1991; Swanson et al., 1997) . Finally, the hypothesis of compensatory synaptic accumulation of GluA1-containing AMPARs was most directly tested by analysis of stereotactic injection of autoantibodies against GluA2 in KO mice deficient for GluA1, which were not able to compensate by GluA1-containing or GluA1 homomeric AMPARs. Thus, human a-GluA2 autoantibodies most likely induce a compensatory synaptic incorporation of GluA1-containing or GluA1 homomeric AMPARs, resembling some aspects of synaptic scaling (Hou et al., 2008; Soares et al., 2013; Turrigiano, 2008) . Although enhanced synaptic incorporation of . ct IgG, saline, or a-GluA2 IgG was continuously infused in both lateral ventricles for 14 days as indicated. Test for locomotor activity (LOC), novel object recognition (NOR) test, and black-and-white maze test (BW) were performed at the indicated time points (sacr, sacrifice; brain slice illustration is modified from Paxinos Mouse Brain Atlas). (C) Horizontal motor activity was unchanged in all experimental groups throughout the experimental period (n (ct IgG) = 11, n (saline) = 12, n (a-GluA2 IgG) = 12).
(D) Object recognition (OR) index in a-GluA2 IgG-infused mice is significantly lower with respect to control groups (ct IgG and saline) at day 10 and day 18, indicating severe impairment of memory function. Note, that animals recover completely on day 25 (n (ct IgG) = 11, n (saline) = 12, n (a-GluA2 IgG) = 12; a-GluA2 IgG versus ct IgG: p < 0.001; a-GluA2 IgG versus saline: p = 0.049; two-way repeated-measurements ANOVA with Holm-Sidak post hoc analysis).
(E) a-GluA2 IgG-infused mice spend less time in the white sector of the BW maze as compared to ct IgG or saline-infused mice (n (ct IgG) = 11, n (saline) = 12, n (a-GluA2 IgG) = 12; a-GluA2 IgG versus ct IgG: p = 0.032; a-GluA2 IgG versus saline: p = 0.008; one-way-ANOVA on ranks with Dunn's post hoc correction).
(F and G) Experimental time course (F) of the intrahippocampal injection passive-transfer model (G). Stereotactic microinjections (3 injection sites per hemisphere; time points indicated by syringes) were performed on 3 consecutive days. Behavioral testing was done at the indicated time points (EPM, elevated plus maze; brain slice illustration is modified from Paxinos Mouse Brain Atlas).
(H) Mice injected with ct IgG or a-GluA2 IgG show no differences in horizontal motor activity (n (ct IgG) = 10, n (a-GluA2 IgG) = 10). (I) OR (object recognition) index in a-GluA2 IgG-injected mice is greatly reduced as compared to controls (p < 0.001). Note that there is a slight reduction of OR index in ct IgG-injected mice after injections in comparison to baseline, which might be due to repetitive anesthesia and surgery before testing (n (ct IgG) = 10, n (a-GluA2 IgG) = 10; p = 0.048; two-way-ANOVA repeatedmeasurements with Bonferroni post hoc analysis).
(J) a-GluA2 IgG-injected mice spend less time in the open arm of the EPM (n (ct IgG) = 9, n (a-GluA2 IgG) = 9; p = 0.004; t test). Data are presented as mean ± SEM. See also Figure S7 .
GluA1 homomeric receptors seems the most likely explanation, we cannot exclude that AMPARs of other subunit composition also contribute to the observed changes in AMPAR signaling. However, increase of synaptic GluA2 and GluA3 heteromers is unlikely since the remaining AMPA receptors show increased inward rectification. As known from previous reports, only very few AMPARs exist as heteromers containing GluA1 and GluA3 subunits (Wenthold et al., 1996) , and it has been shown that after genetic depletion of distinct subunits AMPARs have the ability to assemble as monomers that can be incorporated in synapses (Lu et al., 2009 ). These changes of compensatory synaptic AMPAR restructuring are initiated in post-acute stages after autoantibody-induced receptor internalization. In those early stages, we found first evidence for dissociation of AMPARs and TARPs as channel conductance decreased to typical values of GluA2-containing AMPARs without TARPs (Soto et al., 2009) , whereas this was not observed using GluA2:stargazin fusion proteins. TARPs interact with PDZ proteins, e.g., PSD95, and are responsible for AMPAR targeting to synapses (Bats et al., 2007; Chen et al., 2000) . Autoantibody-induced dissociation of AMPARs and TARPs may thus represent the initial stage of AMPAR uncoupling from anchoring at the postsynaptic density and reflect beginning endocytosis (Tomita et al., 2004) .
Importantly, the resulting situation with increased conductance, greater permeability for Ca 2+ , slower recovery after desensitization, and receptor rectification of the newly incorporated AMPAR may provoke pathological excitatory neurotransmission. This could thus provide an explanation for disease symptoms resulting from hyperexcitability such as epileptic seizures.
Pathophysiology Induced by GluA2 Antibodies and Comparison to Genetic Interference with GluA2
In contrast to germline KO models of GluA2, cell-specific KO or knockdown models of the AMPAR GluA2 subunit share striking similarities with the pathomechanisms induced by anti-GluA2 autoantibodies reported here (Lu et al., 2009) . In this situation of GluA2-deficient neurons, mEPSC amplitudes are largely preserved at resting membrane potential, but their rectification index is strongly reduced (Altimimi and Stellwagen, 2013; Gainey et al., 2009) . Moreover, similar to our recordings, the frequency of mEPSCs at resting membrane potential is reduced (Lu et al., 2009; Panicker et al., 2008) . As human autoantibodies bind at synaptic and extrasynaptic sites and as internalization of AMPARs is inhibited by blocking endocytosis, we suggest that autoantibody-induced pathology leads to internalization of AMPARs, followed by synaptic recruitment of available receptors and scaling mechanisms by insertion of non-GluA2-containing AMPARs.
AMPA Receptor Autoantibodies and Effects on Synaptic Plasticity and Cognitive Function
During synaptic LTP, activated synapses recruit highly mobile extrasynaptic AMPARs to strengthen synaptic transmission (Bassani et al., 2013; Huganir and Nicoll, 2013; Penn et al., 2017; Tardin et al., 2003) . Previous studies have demonstrated that the induction of LTP strongly depends on the number of available AMPARs in the membrane but is independent of their subunit composition (Granger et al., 2013) . Since reduction of GluA2-containing AMPARs was compensated by synaptic incorporation of non-GluA2 AMPARs, the impairment of LTP formation in our experiments can be explained by a reduction of readily available extrasynaptic AMPARs (Huganir and Nicoll, 2013) . Indeed, previous studies have provided evidence that a reduction of the extrasynaptic AMPAR reserve pool may significantly impair the capability of synaptic potentiation (Schroeter et al., 2015) . Recently, it also has been shown that immobilization of AMPARs resulting in reduced surface diffusion impairs synaptic plasticity and finally leads to inhibition of fear conditioning (Penn et al., 2017) .
These deficits in synaptic plasticity (homeostatic and Hebbian) most likely account for the behavioral abnormalities observed in two independent passive-transfer models. Continuous longterm application of GluA2 autoantibodies with osmotic pumps and by repeated microinjection both consistently afflicted memory and cognition. Since all these behavioral alterations follow the microinjection to a rather confined local distribution of the applied IgG preparations in the hippocampus, the pathophysiology is likely linked to limbic structures. This is in line with the typical signs of confusion and difficulties in forming new memories as seen in patients with AMPAR-mediated autoimmune encephalitis (Hö ftberger et al., Joubert et al., 2015) .
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
All animal experiments have been performed according to the ARRIVE guidelines and were approved by the Thuringian state authorities (authorization # 02-059/13). We used male C57BL/6 mice of our own breeding facility (Service Center for small rodents, Jena University Hospital) at an age of 8-10 weeks. Animals were housed on a 12-h dark/12-h light cycle and provided with food and water ad libitum. Mice were randomized for assignment to the respective treatment groups by an investigator not involved in the animal experiments. All experiments were conducted by investigators blinded to animal allocation and treatment groups. Breeding pairs of heterozygous GluA1 and GluA2 deficient mice on a C57BL/6 background were kindly provided by Rolf Sprengel (Max Planck Institute, Heidelberg) and genotyped as described (Jensen et al., 2003; Shimshek et al., 2005) . Homozygous KO mice and WT littermates were used in the experiments for comparison.
METHOD DETAILS
Purification of IgG fractions
In the study we used the purified IgG fraction containing GluA2 ABs from an autoimmune encephalitis patient with high titer (> 1:320) of anti-GluA2 AB in serum and CSF, a pooled IgG fraction of further 8 patients with AMPAR encephalitis, and control IgG without detectable antineuronal ABs derived from a patient with chronic polyneuropathy. Studies were approved by the institutional ethics and review board of Jena University Hospital. IgG fractions were purified from therapeutic plasma exchange material by separation on exchange chromatography as described previously (Geis et al., 2010) . All a-GluA2 AB IgG fractions also contained antinuclear antibodies (ANA) which is an unspecific sign of an active autoimmune state, common in patients with autoimmune disorders of various etiologies, e.g., in multiple sclerosis, Sjö grens syndrome, systemic lupus erythematodes, and even in healthy individuals (Satoh et al., 2012) . This is also a common finding in patients with AMPAR encephalitis suggesting a possible underlying predisposition to autoimmunity (Dalmau et al., 2017; Hö ftberger et al., 2015; Lai et al., 2009) . IgG fractions did not contain any other antineuronal or cell surface AB reactivity (see below and Figure S1 for detailed patient AB testing). The IgG fractions were dialyzed, freeze-dried and stored at À20 C. Lyophilized IgG was dissolved to stock solutions of 5mg/ml or 10mg/ml in normal saline before use.
Binding specificities of patient IgG
The binding specificity of purified patient IgG and of patient IgG depleted of anti-GluA2 ABs was evaluated by cell-based assays using transfected HEK293 cells, immunoprecipitation with CNS tissue, and immunohistochemistry using primary neurons and brain slices of wild-type, GluA1, and GluA2 deficient mice ( Figure S1 ). HEK cell transfection and immunocytochemistry HEK293 cells were maintained in minimal essential medium (MEM; Life Technologies, Carlsbad, CA, USA) with 10% fetal bovine serum (Biochrom, Berlin, Germany), 1% antibiotic-antimycotic solution (Life Technologies) and 1% MEM non-essential amino acids (Life Technologies). Plasmid DNA for transfection was purified by the Plasmid Midi Kit (QIAGEN, Venlo, Netherlands). 2-4 mg of rat GluA1i or GluA2i in pcDNA3.1 plasmid DNA was cotransfected with 100 ng of pEGFP-N2 plasmid DNA (BD Biosciences, Heidelberg, Germany) by a standard calcium phosphate precipitation method. Briefly, after medium exchange, plasmid DNA containing BES buffered saline (BBS) (25 mM N,N-bis-(2-Hydroxyethyl)-2-aminoethanesulfonic Acid (BES, Calbiochem, San Diego, CA, USA), 140 mM NaCl, 0.75 mM Na 2 HPO 4 , pH 6.95) containing 125 mM CaCl 2 for plasmid precipitation was added to cultivated HEK293-cells for 24 h. Thereafter, cells were seeded onto PDL-coated coverslips until usage (up to 2 days after plating). GluA1:eGFP or GluA2:eGFP transfected HEK293-cells were fixated by 4% paraformaldehyde (PFA) for 20 min without permeabilization, washed in phosphate buffered saline (PBS) and incubated for 30min in blocking buffer 1 (BB 1; 5% milk powder, 5% bovine serum albumin (BSA) in PBS). Cells were incubated over night at 4 C with 10 mg/ml anti-GluA2 or control IgG fractions and 2% milk powder in PBS. After washing in PBS, HEK293 cells were incubated for 2 h with secondary Cy3 anti-human AB and 2% milk powder in PBS. After additional washing steps, cells were stained for 5 min with 4 0 ,6-Diamidin-2-phenylindo (DAPI) in PBS, washed again and mounted with Mowiol 4-88 (Calbiochem). Commercial antibodies and applied concentrations are listed in Table S1 . Preabsorption of human IgG HEK293 cells were transfected with GluA1i, GluA2i, and eGFP in a ratio of 5:1:20 in 18 10 cm culture dishes. One day after transfection minimal essential medium was exchanged by neuronal growth medium (Neurobasal, 2% B27, Life Technologies, 1% glutamine, 0.5% penicillin/streptavidin) containing 40mg/ml of the patient IgG fraction. Specific anti-GluA2 ABs in the patients' IgG fractions were able to bind to the GluA2 protein exposed by the HEK293 cells for 45 min. Thereafter, this process was repeated 17 times using the culture dishes with transfected HEK293 cells until specific anti-GluA2 ABs were nearly completely depleted from the IgG fraction. GluA2 transfected HEK293 cells were then used to test successful preabsorption by staining with the depleted IgG fractions as described above.
Affinity purification and mass spectrometry Adult rat brain membrane fractions were solubilized for 30 min at 4 C with 1% Dodecanoylsucrose in 50 mM Tris/HCl pH 8.0, 150 mM NaCl at 1 mg protein/ml. Non-solubilized matter was removed by ultracentrifugation for 15 min at 125,000 g. Supernatants containing 3 mg solubilized membranes were incubated for 4 h at 4 C with 30 mg human IgG fractions covalently immobilized on Protein G Dynabeads (Thermo Fisher). After three subsequent washes with solubilization buffer, immunoprecipitates were eluted in Laemmli buffer without dithiothreitol at 37 C. Denatured eluates were analyzed by immunoblot using anti-GluA2/3 (Millipore #07-598) and anti-GluA1 (Millipore #AB1504) primary antibodies (each used at 1:1000) and goat anti-rabbit secondary antibodies (Santa Cruz #sc-2004, 1:20,000). Mass spectrometric (MS) analysis of whole eluates was performed using a nano-LC-MS/MS system (LQT Orbitrap Velos, Thermo Fisher) by the Biomedizinisches Forschungszentrum (BMFZ), Heinrich-Heine Universit€ at D€ usseldorf. MS data was searched against the UniProt knowledgebase release 2017_02 rat reference proteome using MaxQuant (version 1.5.8.3) with standard settings (PSM and protein level FDR = 0.01%) and the following variable modifications: methionine oxidation, acetylated protein N-termini, Glu/Gln / pyro-Glu. A minimum of two unique peptides was required for unambiguous protein identification.
Brain slice immunohistochemistry
Mice were deeply anesthetized with isoflurane and perfused with 4% of PFA by cardiac puncture to obtain brain slices for immunohistochemistry. Brains were prepared, afterfixated for 24 h in 4% PFA, and dehydrated for 24 h in 10% and 24 h in 30% sucrose solution. Thereafter, free-floating 40 mm serial sections were prepared. Slices were blocked with BB 2 (3% normal goat serum, 2% milk powder and 0.1% Triton X-100 in TRIS buffered saline [TBS]) for 30 min. Thereafter, slices were incubated overnight at 4 C with primary AB (GluA2, GluA1), or patient IgG fractions in BB 2. After washing steps in TBS slices were incubated for 2h with secondary AB (Rhodamin anti-mouse, Rhodamin anti-rabbit, Cy3 anti-human). After additional washing in TBS slices were transferred to object slides with 0.5% gelatin, dried, stained for 5 min in DAPI solution, washed in PBS and mounted with Fluoromount (Southern Biotech, Birmingham, AL, USA).
Immunocytochemistry on primary neurons
Primary hippocampal neurons were prepared from C57BL/6 E18 embryos as described earlier (Haselmann et al., 2015) . Briefly, embryonic brains were removed from the skull and meninges were removed with a fine forceps. Hippocampi were separated, trypsinated in 0.25% Trypsin solution for 5 min at 37 C and triturated. Neurons were first plated on PDL-coated coverslips in plating medium (MEM, 0.5% glucose, 10% horse serum, 0.5% penicillin/streptavidin) with a density of 20.000 cells/cm 2 . After 1 h plating medium was replaced by growth medium (Neurobasal, 2% B27 [Life Technologies], 1% glutamine, 0.5% penicillin/streptavidin) and neurons were cultured for 10 to 15 days before use. After 14 days in vitro (DIV) neuronal cultures were fixed for 20 min with 4% PFA, washed with PBS and blocked for 30 min with BB 3 (10% BSA/PBS, 0.1% Triton X-100). Afterward, cells were incubated with a-GluA2 IgG (10 mg/mL) and Homer1 AB overnight at 4 C. After washing steps in PBS cells were incubated with secondary AB (Cy3 anti-human for a-GluA2-IgG and Alexa488 anti-guinea pig for Homer1; see also Table S1) for 2 hours at room temperature. After repeated washing steps in PBS, neurons were stained in DAPI solutions for 5 min, washed again and mounted with Moviol.
Confocal and dSTORM imaging
Immunostaining (primary neurons) Primary hippocampal neurons were incubated with a 1:500 dilution of 5 mg/ml stock of anti-GluA2 IgG or control IgG for 24 h at 37 C followed by paraformaldehyde fixation (PFA, 4% for 20 min at room temperature (RT)). In a subset of experiments, neurons were incubated with the cathrin-inhibitor pitstop2 (0.03 mM in DMSO; Sigma-Aldrich) and GluA2 IgG or control IgG for 24 h. Primary staining antibodies (against human IgG, GluA1 or GluA2, see also Table S1 ) were then applied overnight at (4 C) in BB 4 (PBS, 10% bovine serum albumin, 10% normal goat serum, 10% normal donkey serum, 0.1 M glycine). Samples were washed in PBS+ (PBS + 0.1 M glycine) six times for 5 min, permeabilized 1 h (at RT) with BB 4 containing 0.1% Triton X-100 and incubated with anti-Homer1 antibodies (2 h, at RT), washed again six times and subsequently incubated with secondary antibodies (2 h, RT). In a subset of experiments we performed sequential staining of GluA2. Surface receptors were stained with commercial antibodies to GluA2 and excess secondary antibody (anti-mouse AlexaFluor 647) without permeabilization followed by washing steps, permeabilization with 0.1% Triton X-100, and subsequent GluA2 staining with secondary anti-mouse Rhodamin Red-X antibodies. After immunostaining samples were washed with PBS+ and postfixed with 4% PFA at RT for 10 min. Samples were kept in PBS+ until recording for dSTORM and were embedded in Moviol for confocal analysis Confocal microscopy (primary neurons) Immunostained primary neurons were imaged on Zeiss LSM 710 confocal microscope using the laser lines for excitation of Alexa Fluor 532, Rhodamine-X, and Cy5 (514 nm, 561 nm, and 633 DPSS laser lines, respectively). All recording parameters (PMT gain, laser power, pixel size, pixel dwell time, z-step size) were kept constant during the experiment. Pixel size and z-step size were selected according to Nyquist criterion (102 nm pixel size and 150 nm z-step size). Channel alignment was performed by recording tetraspecks beads (Life technologies) and applying transformations in ZEN software (Zeiss).
Confocal microscopy (hippocampal sections)
To quantify the effects of patients' ABs on total cell-surface and synaptic AMPAR clusters (GluA1 GluA2) and PSD95, non-permeabilized 5 mm brain sections were blocked with 5% goat serum, incubated with commercial anti-GluA1 or GluA2 antibodies for 2 hours at RT, washed with PBS, permeabilized with Triton X-100 0.3% for 10 minutes at RT, and serially incubated with rabbit polyclonal anti-PSD95 overnight at 4 C, and the corresponding secondary antibodies, for 1 hour at RT (concentrations used for antibody staining see Table S1 ). Slides were mounted and results scanned with a confocal microscope (Zeiss LSM710). Standardized z stacks including 50 optical images were acquired from 10 hippocampal regions per animal including CA1 and DG. dSTORM recordings Samples were recorded in MEA buffer containing 100 mM mercaptoethylamine (pH adjusted to 7.9) with a Zeiss Elyra P.1 setup equipped with DPSS laser lines of 561 nm and 642 nm (Lasos Lasertechnik, Jena, Germany) and two EMCCD cameras (Ixon DU 897; Andor, Belfast, UK). All settings were kept constant throughout the experiments to allow relative quantification of experimental groups. Fluorophores were excited using the above laser lines starting with the longer wavelength excitation (sequential acquisition) using a 1.46 NA 100x TIRF oil objective (Zeiss, Jena, Germany). 90% of 561 nm laser and 14% of 642 nm laser line were constantly applied during experiments. Emission was filtered using appropriate filter sets. For each channel 15000 frames were recorded with a framesize of 320x320 px applying a camera exposure time of 25 ms and an in-software 250 detector gain. Sample z-drift was stabilized using Definite Focusª (Zeiss). Residual drift in x-y direction was corrected using a model based drift algorithm implemented in ZEN 2009 software (Zeiss). Chromatic aberration was corrected by performing a channel alignment using tetraspeck beads.
Stereotactic intravital IgG injections
Stereotactic injections of IgG fractions into the hippocampus were performed as previously described (Haselmann et al., 2015) . Briefly, 151 eight week old C57BL/6 WT and 35 GluA1 deficient mice were deeply anesthetized by 1.5 to 2.0% of isoflurane/oxygen and head fixed into a stereotactic apparatus (Lab StandardTM, Stoelting, Wood Dale, IL, USA). The skull was exposed by a small midline incision, the stereotactic injection sites were marked (for exact coordinates see Table S2 ), and holes were drilled with a dentist driller (Foredom, Bethel, CT, USA). Very thin injection pipettes were pulled from borosilicate glass (WPI, Sarasota, FL, USA, #4878) and filled with IgG solutions (concentration 5mg/ml) or 0.9 M saline solution (total volume 4 ml). For electrophysiological measurements 1 mM of FM1-43-FX (Molecular Probes) was added to the solutions for intravital visibility and verification of the injection site in acute slices. The injection pipette was placed at stereotactic coordinates as detailed in Table S2 and 1 ml of IgG solution was injected with an injection speed of 0.4 nl/s by a microprocessor controlled nanoliter injector (Nanoliter 2000 + SYS-Micro4 Controller, WPI) per injection site. By using very thin glass application pipettes, low injection volume, and slow injection speed tissue damage in the target region is avoided. After injections the skin of the animals was sutured and mice were taken back to their home cage for at least 24 h for regeneration.
Placement of intraventricular catheters 36 male C57BL/6J mice were used for implantation of intraventricular catheters. Animal care, anesthesia, insertion of bilateral ventricular catheters (PlasticsOne, model 3280PD-2.0/SP; coordinates: 0.2 mm posterior and ± 1.00 mm lateral from bregma, depth 2.2 mm), and connection of each catheter to a subcutaneous osmotic pump for continuous infusion of purified IgG fractions (Alzet 1002, Cupertino, CA; volume 100 ml, flow rate 0.25 ml/h for 14 days) was done as previously reported (Planagumà et al., 2015 (Planagumà et al., , 2016 . Osmotic pumps were filled with IgG preparations the day before surgery (concentration for IgG preparations 10mg/ml; 12 mice with anti-GluA2 AB, 11 mice with control IgG, 13 mice with 0.9 M saline).
Behavioral tests Novel object recognition (NOR) test
Animals were habituated for 45 minutes in a 45x45x40 cm open field arena (Panlab, Barcelona, Spain) two days before surgery. On the day of the test, animals were again placed in the arena and two identical objects were presented on the opposite corners. After 9 min of exploration, mice were taken back to their home cage. Three hours after the familiarization phase, animals were placed in the open field box, in which one familiar object was replaced by a novel one. Times of exploration of both familiar and novel object were manually recorded over 9 minutes. The novel object was presented in 50% of trials in the right side and in 50% of trials in the left side. Every nose poke or orientation of the nose to the object at less than 2 cm distance was considered an exploration event. The OR index was calculated as the difference between times of exploration of novel and familiar objects respectively, divided by the total time spent exploring both objects. Animals who received bilateral intrahippocampal injections were tested 72 hours before the first and 24 hours after the last injection. Animals that received intraventricular infusion by osmotic pumps were tested on days 3, 10, 18 and 25 after surgery, as described previously (Planagumà et al., 2015 (Planagumà et al., , 2016 . Locomotor activity test Animals were assessed in locomotor activity boxes (11 3 21 3 18 cm; Imetronic, Passac, France), equipped with 2 rows of photocell detectors, and placed in a dark environment, similarly to previously described protocols (Planagumà et al., 2015 (Planagumà et al., , 2016 . The mouse locomotor activity was recorded for 60 minutes and differentially classified for local motor activity, horizontal activity and rearings. Animals were habituated to the apparatus the day before the surgery. Mice treated with bilateral intrahippocampal injections were tested 72 hours before the first and 24 hours after the last injection. Mice treated with continuous intraventricular infusion were tested on days 3, 10, 18 and 25 after surgery.
Elevated plus maze (EPM) test
The EPM was custom-made of gray Perspex (TSE Systems Inc., Bad Homburg, Germany) and had two sets of opposing arms (30x5 cm) extending from a central platform (5x5 cm). Two arms were enclosed by 15 cm high walls. The remaining two arms were open and surrounded by a slightly raised lip (0.25 cm). The apparatus was elevated 100 cm above floor level and illuminated by a central 25 W light bulb. Illumination intensity was 70 lux in the open arms and 50 lux in the closed arms, respectively. Mice were placed in the center, facing to an open arm and were allowed to freely explore the maze for 10 min. The number of arm entries and the amount of time spent in the open and closed arms as well as the speed and the total distance traveled were recorded using a camera tracking system (EthoVision, Noldus, Wageningen, Netherlands). After each trial the EPM was cleaned with 70% ethanol ensuring identical experimental conditions for all subjects.
Black-and-white (BW) test
The protocol was adapted according to previously published methods (Planagumà et al., 2015) . The BW maze consists of a blackpainted wall compartment (16x25x24 cm) and a white-painted wall compartment (25x25x24 cm) connected by a 7 cm wide by 7 cm high opening (Panlab). Lightning in the black compartment was maintained at 30 lux, while the white compartment was brightly illuminated (500 lux), and subdivided in 3 sections (distal, medial and proximal), based on the distance from the opening. At the start of the session, mice were placed in the medial sector of white compartment, head facing one lateral side of the box. The distance traveled, the total number of entries and the time spent were calculated for both compartments for 5 min. The BW test was performed on day 24 after bilateral pump implantation.
Immunoprecipitation after microinjection
Under a dissection microscope (Zeiss stereomicroscope, Stemi 2000), the hippocampi were isolated, weighted, snap frozen and stored at À80 C. Tissue (12 mg) was placed in 0.5 mL ice-cold lysis buffer (NaCl 150mM, EDTA 1mM, 100 mM tris (hydroxymethyl) aminomethane [Tris]-HCl, 0.5% deoxycholate acid, 1% Triton X-100, pH 7.5) with protease inhibitors (Sigma-Aldrich, 1:50) and homogenized through a 23G needle syringe. After 1h incubation at 4 C, tissue was centrifuged at 16000 g for 5 min and supernatant incubated with protein A/G agarose beads (Pierce) for 2h at 4 C. Beads were then washed, resuspended in Laemmli buffer, boiled for 5 minutes, separated in a 4 to 15% sodium dodecyl sulfate polyacrylamide gel electrophoresis, and transferred to a nitrocellulose membrane. The membrane was first incubated with a polyclonal rabbit antibody against GluR2/3 (1:200, Millipore) and a monoclonal mouse antibody against beta-Actin (1:20000, Sigma) overnight at 4 C. Then, membranes were incubated with secondary antibodies for 1 h at room temperature (anti-rabbit IgG HRP 1:1000, anti-mouse IgG HRP 1:1000) and analyzed by enhanced chemiluminescence (all Amersham GE Healthcare) on a LAS4000 (GE Healthcare).
Immunohistochemistry for determination of bound IgG upon stereotactic injection
For determination of IgG bound to brain tissue after stereotactic IgG injections using immunoperoxidase staining, 7 mm-thick tissue sections were sequentially incubated with 0.25% H 2 O 2 for 10 minutes at 4 C, 5% goat serum for 15 minutes at room temperature (RT), biotinylated goat anti-human IgG (1:2000, Vector labs, Burlingame, CA, USA) overnight at 4 C, and the reactivity developed using avidin-biotin-peroxidase and diaminobenzidine. Sections were mildly counterstained with hematoxylin.
Golgi-Cox staining
Morphological dendrite and spine analysis were performed in pyramidal neurons of the CA1 region from the hippocampus of mice after stereotactic intrahippocamal injection. Directly after removal of the mouse brain, brains were cut into hemispheres and one hemisphere was used for further analysis. Golgi silver impregnation was conducted with the FD Rapid GolgiStainTM Kit (FD NeuroTechnologies, Inc., Columbia, USA) according to manufacturer's instructions. Briefly, the tissue was rinsed in ACSF to remove blood residues, and was then transferred into equal amounts of solution A+B of the FD Rapid GolgiStainTM Kit. After renewal of solutions on the second day the tissue was subsequently left in the dark for 2 weeks at room temperature. Thereafter, brain hemispheres were transferred into solution C of the FD Rapid GolgiStainTM Kit, which was changed after one day, and were left in solution at 4 C for 5 days. Hemispheres were then stored at À80 C until further use. Then, hemispheres were cut into 150mm thick coronal slices in the area of the hippocampus using a Leica CM3050S cryostat and mounted on object slides. For the last step of staining procedure, slices were washed in purified water (2x4 min), incubated in a mix of 1/4 solution D, 1/4 solution E and 1/2 purified water for 10 minutes, washed again, and then dehydrated in an ascending alcohol series (50%, 75%, 95% for 4 min each, and 2 3 100% for 8 min). Finally, slices were immersed in xylene (2x5 min), and then quickly coverslipped with EntellanÒ (Merck KGaG,Darmstadt, Germany) and dehumidified overnight.
Electrophysiological studies
All electrophysiological measurements except for outside-out patch recordings were performed with a HEKA EPC10 amplifier with a sampling rate of 20 kHz and all recordings were filtered at 2.9 and 10 kHz using Bessel filters of the amplifier unless otherwise stated. Series resistance was compensated (60 -80%) and monitored constantly. Cells with series resistance > 25 MU or series resistance changes of > 20% during measurement were discarded. Liquid junction potential of 10 mV was corrected offline for all whole-cell patch clamp recordings unless otherwise stated. Whole-cell patch clamp recordings Primary hippocampal cultures of neurons 10 to 15 days in-vitro were used for whole-cell patch clamp recordings. Before recording, neuronal cultures were incubated with a-GluA2 IgG, preabsorbed a-GluA2 IgG or control IgG for 24 h (20 mg/ml). For determination of short-term effects of a-GluA2 IgG, neuronal cultures were preincubated with IgG fractions for 25 ± 2 or 59 ± 2 min. Recording electrodes were pulled from thick walled borosilicate glass (2.0 mm o.d., Science Products, Hofheim, Germany) and filled with intracellular recording solution containing 125 mM CsMeSO 3 , 10 mM HEPES, 10 mM EGTA, 8 mM NaCl, 1 mM CaCl 2 , 2 mM Mg-ATP, 0.3 mM Na-GTP, 5 mM QX-314 bromide (Tocris, Bristol, UK), 0.1 mM spermine tetrahydrochloride (Sigma-Aldrich) adjusted to pH 7,25 and an osmolarity of 310 mOsmol and had a final resistance of 3 -5 MU. For evaluation of AMPAR mediated mEPSCs whole cell voltage clamp measurements were performed for 100 s at holding potentials of À80 mV or +40 mV, respectively, in artificial cerebrospinal fluid 1 (ACSF 1; 125 mM NaCl, 25 mM NaHCO 3 , 25 mM glucose, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 1 mM MgCl 2 , 2 mM CaCl 2 , purged with 95% O 2 /5% CO 2 ) containing 50 mM AP-5 (Tocris), 20 mM bicuculline (Sigma-Aldrich) and 1 mM of TTX (Tocris). In some experiments 1-naphthyl acetyl spermine trihydrochloride (NASPM, Tocris) was added to block currents that were mediated by AMPARs without GluA2 subunits (Koike et al., 1997) . In a separate experiment, dissociated neurons were incubated with 80 mM ryanodine for 2 to 3 days before recordings to block the ryanodine receptor according to previous reports (Vlachos et al., 2013) .
Single-synapse glutamate iontophoresis
For evaluation of single-synapse evoked EPSCs, presynaptic boutons of the neurons were stained using 20 mM of FM1-43-FX dye (Molecular Probes) and stimulation with high potassium ACSF (39 mM NaCl, 30 mM glucose, 25 mM HEPES, 90 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , pH7.4) for 60 s (Figure 2A ). Thereafter neurons were perfused with ACSF1 containing 50 mM AP-5 and 20 mM bicuculline for at least 10 minutes. This results in clearly labeled synaptic spots that are visible in vital neurons during patch-clamp recordings (Geis et al., 2010) . Neurons were voltage-clamped at À80 mV in whole cell configuration. ieEPSCs were evoked by singlesynapse glutamate iontophoresis. FM1-43-FX stained synaptic terminals were stimulated by sharp thin-walled borosilicate glass pipettes (inner diameter 1.05; Science Products) filled with intracellular solution containing 150 mM sodium L-glutamate (Sigma-Aldrich) in ACSF1 with a final resistance of 40 -60 MU. In some experiments Alexa 555 (Molecular Probes) was added for visualization of iontophoretic glutamate application. Stimulation was performed by a short iontophoretic application mimicking synaptic transmission using a MVCS-02 amplifier (NPI, Tamm, Germany) (Murnick et al., 2002) . After the pipette was placed directly adjacent to the FM1-43-FX stained boutons, iontophoretic stimulation was performed for 1 ms with iontophoretic eject currents of À100 or À750 nA and a retain current in the range of 4 to 12 nA. For single-and multisynaptic recordings the mean of 10 consecutive trials was taken for further analysis. Recovery after desensitization was measured as the ratio between means of the 2 nd and 1 st eEPSCs at different interstimulus intervals ranging from 25 to 1000 ms at 750 nA eject current. Outside-out recordings in tsA201 cells tsA201 cells were transiently transfected with GluA1 (in a pIRES-mCherry vector) and GluA2 (in a pIRES-GFP vector) or a tandem protein of fused GluA2 with stargazin (GluA2:stargazin with a 9 aa linker) in a 1:2 ratio by using polyethylenimine (PEI) transfection method (3 mg of PEI per 1 mg DNA) in serum-free media for recordings of acute effects of a-GluA2 IgG and with GluA1, GluA2 and g2 (stargazin) in either 1:2:2 or 3:4:4 ratios for measurements of the influence of a-GluA2 IgG on internalization and the interaction of GluA2 with auxiliary subunits. After 3 hours of transfection cells were split and yielded in glass coverslips treated with poly-L-lysine at the proper density to allow the presence of isolated cells. Electrophysiological recordings were done 18-24 h after transfection. Untagged GluA2 subunit presence was determined by rectification index (see below). Transfected cells were visualized with an inverted epifluorescence microscope (Axio-Vert.A1; Zeiss). Cells were continuously perfused at RT with extracellular physiological solution (ACSF2): 145 mM NaCl, 2.5 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, and 10 mM glucose, adjusted to pH 7.4 with NaOH.
For recordings of acute effects of a-GluA2 1 mM glutamate plus 50 mM cyclothiazide (CTZ) were locally applied by gravity through a theta glass. After 25-30 s of the activation of the AMPAR-mediated current, solution was rapidly changed by piezoelectric translation (P-601.30; Physik Instrumente) of a theta-barrel application tool made from borosilicate glass (1.5 mm o.d.; Sutter Instruments) to a solution containing 1mM glutamate, 50 mM CTZ plus ct IgG or a-GluA2 IgG for 10 s at a holding potential of -60 mV. A single +60 mV pulse of 5 s duration was applied to calculate the rectification index. Electrodes with open-tip resistances of 2-4 MU were made from borosilicate glass (1.5 mm o.d., 1.16 mm i.d., Harvard Apparatus), pulled with a P-97 horizontal puller (Sutter Instruments) and filled with intracellular pipette solution containing (in mM): 145 mM CsCl, 2.5 mM NaCl, 10 mM HEPES, 1 mM Cs-EGTA and 4 mM MgATP, adjusted to pH 7.2 with CsOH. Spermine tetrahydrochloride (Sigma Aldrich) was added to the intracellular solution at 100 mM in all experiments. Currents were acquired at 5 kHz and filtered at 2 kHz by means of Axopatch 200B amplifier, Digidata 1440A interface and pClamp10 software (Molecular Devices Corporation).
For experiments investigating the influence of a-GluA2 IgG on GluA2 internalization and interaction of GluA2 with auxiliary subunits, cells were treated with control-IgG or a-GluA2-IgG (20 mg/mL) diluted in extracellular solution during 4 minutes at 37 C prior to recordings. Out-side out recordings were performed 25.17 ± 2.87 minutes after ct IgG treatment and 25.58 ± 4.34 minutes after a-GluA2 IgG treatment. 10 mM Glutamate (Sigma-Aldrich) was applied to outside-out patches for 100 ms at a frequency of 1Hz. Electrodes with open-tip resistances of 6-10 MU were made from borosilicate glass (1.5 mm o.d., 0.86 mm i.d., Harvard Apparatus). At the end of each recording, the adequacy of the solution exchange was tested by destroying the patch and measuring the liquid-junction current at the open pipette (10%-90% rise time normally 400-500 ms). Currents were acquired at 50 kHz and filtered at 10 kHz. Preparation of acute hippocampal slices Mice with stereotactic injections into the dentate gyrus (DG) of the left hemisphere were decapitated. The brain was removed in icecold protective cutting ACSF (95 mM N-Methyl-D-glucamine, 30 mM NaHCO 3 , 20 mM HEPES, 25 mM glucose, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 2 mM thiourea, 5 mM sodium ascorbate, 3.0 sodium pyruvate, 10 mM MgSO 4 , 0.5 CaCl 2 , 12 mM N-acetylcysteine, adjusted to pH 7.3 and an osmolarity of 300 to 310 mOsmol, purged with 95% O 2 /5% CO 2 ) (Peç a et al., 2011) and cut into two halves. The olfactory bulb of the injected hemisphere was cut in the coronary plane and the hemisphere was glued with the cut face onto the probe-holder with superglue (UHU, B€ uhl, Germany). 300 mm thick coronal slices were made with a vibratome (VT1200S; Leica, Wezlar, Germany) with an amplitude of 1 mm and a velocity of 0.4 mm/s. Slices were given into an incubation beaker with protective cutting ACSF at 34 C for 10 to 15 min and then transferred into another incubation beaker with protective storage ACSF (125 mM NaCl, 25 mM NaHCO 3 , 25 mM glucose, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 1 mM MgCl 2 , 2 mM CaCl 2 , 2 mM thiourea, 5 mM sodium ascorbate, 3 mM sodium pyruvate, 12 mM N-acetylcysteine, adjusted to pH 7.3 and an osmolarity of 300 to 310 mOsmol, purged with 95% O 2 /5% CO 2 ) until use. For LTP recordings in the Schaffer collateral (SC) -CA1 synapse the brain was cut into 400 mm thick coronal slices in high sucrose cutting ACSF (40 mM NaCl, 25 mM NaHCO 3 , 10 mM glucose, 150 mM sucrose, 4 mM KCl, 1.25 mM NH 2 PO 4 , 0.5 mM CaCl 2 , 7 mM Mg 2 Cl; purged with 95% O 2 /5% CO 2 , pH 7.35), and transferred into ACSF3 (124 mM NaCl, 26 mM NaHCO 3 , 10 mM glucose, 3.4 mM KCl, 1.2 mM NaH 2 PO 4 , 2 mM CaCl 2 , 2 mM MgSO 4 , purged with 95% O 2 /5% CO 2 , pH 7.35) for 1 h at 34 C and subsequently at RT for at least 60 additional minutes. Patch-clamp recordings in acute brain slices The injection site of the stereotactic application of AB solutions or saline was identified by FM1-43-FX localization in the DG. Wholecell recordings from granule cells were obtained with recording electrodes pulled from thick-walled borosilicate glass (2.0 mm o.d.) and filled with intracellular recording solution. AMPAR mediated mEPSCs in hippocampal granule cells of WT and GluA1 deficient mice were recorded for 100 s at holding potentials of À80 mV in ACSF1 containing 50 mM AP-5, 20 mM bicuculline, and 1mM TTX. In some experiments NASPM was added to selectively block non-GluA2 containing AMPARs. For measurements of eEPSCs the lateral perforant path was stimulated by a theta glass bipolar stimulation electrode (Harvard Apparatus, Holliston, MA, USA) filled with ACSF1 and connected to a stimulus isolation unit (Isoflex, A.M.P.I, Jerusalem, Israel). eEPSCs were recorded at À80 mV holding potential. Supramaximal stimulation was determined when increasing stimulation did not result in increase of eEPSC and ranged from 300 -500 mA. Paired-pulse facilitation interstimulus interval of 50 ms was measured with supramaximal stimulation. Field potential recordings For field potential measurements single slices were transferred into a measurement chamber with perfusion of ACSF3 at 1.3 to 2.5 ml/min at 32-33 C. A custom made platinum stimulation electrode was placed in the Schaffer Collateral (SC) pathway. Recording electrodes were filled with ACSF3 and placed in the stratum radiatum of the CA1 region for fEPSP recordings. A stimulus isolation unit (Isoflex, A.M.P.I.) was used to elicit stimulation currents between 25-400 mA to record input-output characteristics. Stimulation was then adjusted in each recording to evoke fEPSP at which the population spike could first be distinguished from the field potential and was then reduced by 10% (Grover et al., 2009; Planagumà et al., 2016) . After baseline recordings for 20 minutes with 0.03 Hz, LTP was induced by theta-burst stimulation (TBS; 10 theta bursts of 4 pulses of 100 Hz with an interstimulus interval of 200 ms repeated 10 times with 0.03 Hz) resulting in stable potentiation after short depression immediately after TBS (Planagumà et al., 2016; Raymond, 2007) . After LTP-induction, fEPSPs were recorded for additional 60 minutes with 0.03 Hz. Slopes of all recordings were measured directly after fiber volley to the peak of the fEPSP or until the beginning of a clearly distinguishable population spike. Paired-pulse stimulation was performed before and after TBS with an interstimulus interval of 100 ms. For input-output and paired-pulse measurements the average slope of 5 fEPSPs was used for data analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data Analysis
Analysis of dSTORM images Localizations were calculated in Zeiss ZEN software by Gaussian fitting using a peak mask size of 9 pixel and a signal-to-noise threshold of 8 (receptor signals, Alexa 647) or 11 (Homer1 signal, CF568), respectively. Rarely, overlapping molecules localizations had to be discarded by the software. Localization raw data were further analyzed with a custom written Mathematica script. For Homer1 signal sparse localizations were excluded by a nearest neighbor analysis rejecting all localizations that have less than 10 neighbors within a radius of 40 nm to allow precise determination of PSD clusters. For characterization of postsynaptic Homer1 clusters an alpha shape algorithm (alpha = 40) was used. Preceding tests were performed with a series of alpha values that showed reliable reports of PSD size approaching areas measured with electron microscopy and PALM (MacGillavry et al., 2013; Schikorski and Stevens, 1997) (Figure S3C ). We also compared this algorithm with the results from a density based clustering algorithm (DBSCAN; applied with parameters epsilon = 40 and minPoints = 5) that yields similar synaptic GluA2 densities and trends in group comparisons ( Figure S3C ). Our selected cluster determination method (alpha shapes, alpha value = 40) showed no differences in PSD area between control and treatment group. Clusters were selected that were within a size range of 20.000 -300.000 nm -2 and a minimum of 100 photons representing post-synaptic regions according to published PALM measurements of PSD size ( Figure  S3B ) (MacGillavry et al., 2013) . Resulting clusters were taken as regions of interest and localizations of receptors (second channel) were classified as intra-or extrasynaptic receptors according to the measured receptor-cluster distance. Previous studies estimated an average distance in the 2D projection between Homer1 signals and post-synaptic receptor localizations of about 50 nm using superresolution microscopy (Dani et al., 2010) . We therefore classified all receptor localizations within 50 nm of Homer1 clusters as synaptic receptors and those with a cluster-receptor distance between 50 nm and 2000 nm as extrasynaptic receptors ( Figure  S3A ). The number of synapses per dendrite length was estimated by dividing the number of detected Homer1 clusters by the longest distance within the dendrite region of interest (manually drawn). To interpret the distance distributions of measured data we used a Mathematica algorithm to simulate randomly located extrasynaptic receptor localizations within the extrasynaptic space. These random receptor distributions showed distributions without synaptic adherence as observed in our original measurements. Analysis of confocal images (primary neurons) Z stacks were imported in Bitplane Imaris for further processing. Homer 1 signal was used to create synaptic ROIs (volumetric surface) by intensity based thresholding (constant parameters applied for group comparisons). Sum intensities of synaptic receptor signals were extracted and related to surface volume of postsynaptic areas (intensity/mm -3 ). Extrasynaptic volume was defined by applying a low threshold on Homer 1 signal (intensity = 1000 at 16 bit) and restricting dendritic regions to approximately 30 mm proximal dendritic length by cutting dendritic volumes by hand. Sum of receptor signals (subtracted by synaptic intensities) related to this extrasynaptic volume (subtracted by postsynaptic volume) yielded extrasynaptic densities of AMPA receptor subunits. Analysis of confocal images (brain sections) Optical images were deconvolved using the theoretical point spread function with AutoQuant software (Bitplane). For cluster density analysis a spot detection algorithm from Imaris suite 7.6.4 (Bitplane) was used. Density of clusters in each hippocampal region was expressed as spots/mm 3 . Synaptic localization was defined as co-localization of GluA1 or GluA2 with post-synaptic PSD-95, and synaptic cluster density was expressed as colocalized spots/mm 3 . The mean densities of all 10 hippocampal regions were calculated for total and synaptic GluA1 or GluA2. Determination of bound IgG in brain slices Results were photographed under a LSM710 Zeiss microscope equipped with a HRc Axiocam color CCD camera (Jena, Germany). Images were prepared creating a mask for diaminobenzidine color, converting the mask to gray scale intensities, and inverting the pixels using Adobe Photoshop CS6. Brain sections were manually outlined; intensity and area were quantified using the public domain Fiji ImageJ software (http://fiji.sc). Values were normalized to the patients' IgG (defined as 100%, animals injected with a-GluA2 IgG). Synaptic spine analysis in brain sections To evaluate dendritic morphology, a Zeiss Axioskop 2 mot plus and a computer-based system (Neurolucida; MicroBrightField) was used to generate three-dimensional neuron tracings that were subsequently analyzed using the NeuroExplorer Software (MicroBrightField). Golgi-impregnated cells were selected for reconstruction if they fulfilled the following criteria: (1) the neuron was located in the CA1 region (2) the neuron was distinguishable from neighboring cells to allow for identification of dendrites, (3) the dendrites were not truncated or broken, and (4) the cell exhibited dark and well filled impregnation throughout whole dendrites including spines. For analysis of dendritic spines, positively stained neurons in the CA region were randomly selected. Neuronal apical dendrites were followed up to tertiary branches without visible disruptions and without further split up using a Zeiss Axioskop 2 mot plus with a 100x oil immersion objective (PLAN-Neofluar, Zeiss). For correct analysis of dendrite length, tertiary branches were chosen to be in an even z-layer. Number and type of spines (mushroom, stubby, thin) were counted manually by the same blinded investigator. Total spine density was calculated as number of spines per 10 mm of dendritic length. Morphological subclassification was outlined in proportion of all spines.
Non-stationary fluctuation analysis
To determine single-channel conductance values from macroscopic deactivating currents in transfected tsA201 cells, we used nonstationary fluctuation analysis (NSFA) as previously described (Gratacò s-Batlle et al., 2015) . The single channel current (i) was calculated by plotting the ensemble variance against mean current (I) and fitting with Sigworth parabolic function. where s 2 B is the background variance and N the total number of channels contributing to the macroscopic response. The weightedmean single-channel conductance was inferred from the single-channel current and the holding potential of À60mV corrected for the theoretical liquid-junction potential (+4.9 mV; pClamp 10).
The rectification index (RI) was defined as the absolute value of glutamate-evoked peak current at +60 mV divided by peak current at À60 mV: RI + 60mV=À60mV = jI + 60mV j jI À60mV j :
The kinetics of desensitization of the AMPAR responses were determined by fitting the glutamate-evoked responses at a holding potential of -60 mV to a double-exponential function to determine the weighted time constant (t w,des ):
where A f and t f are the amplitude and time constant of the fast component of desensitization and A s and t s are the amplitude and time constant of the slow component of desensitization.
To determine the single channel conductance and the number of AMPARs in granule cells of hippocampal brain sections we performed peak-scaled NSFA as previously described (Traynelis et al., 1993) . In short, Igor Pro 6 or 7 was used to peak-scale EPSCs of 140 (wt slices) or 120 (ko slices) sweeps elicited by maximal stimulation, to filter the traces with a Gaussian low-pass filter with a À3 dB cut-off frequency of 500 Hz, and to calculate the average (I(t)) and the variance (s 2 (t)) of each time point of the EPSC. The analysis was restricted to the decay of the average EPSCs from $80 to $10% of the peak and plotted as described above.
Analysis of whole cell recordings
Traces of electrophysiological recordings were analyzed by NeuroMatic plugin (http://www.neuromatic.thinkrandom.com) of Igor Pro Software (Wavemetrics, Portland, OR, USA). Erroneous traces (high noise, spontaneous input interfering with evoked inputs) were discarded manually before analysis. mEPSC data was analyzed by Mini Analysis software (Synaptosoft, Decatur, GA, USA) using AMPAR mediated mEPSC compatible templates. The automatically detected events were then visually examined and erroneous events were rejected from further analysis.
Statistical Analysis
Electrophysiological and dSTORM data were checked for normal distribution. Unless not otherwise stated the two-tailed Student's t test or the non-parametric Mann-Whitney U-test were applied for comparing individual groups depending on normal distribution. For statistical comparison of multiple groups one-way ANOVA with Tukey's post hoc test or ANOVA on Ranks with Dunn's post hoc test was used according to data distribution. For comparison of the time-course in LTP recordings we used repeated-measurements two-way ANOVA test with Holms-Sidak post hoc test. Behavioral tests with multiple time points (NOR and locomotor activity) were analyzed using repeated-measurements two-way ANOVA. Multiple comparisons were corrected using Bonferroni post hoc test. Behavioral tests with single time point (BW and EPM) were analyzed using two-tailed Student's t test or the non-parametric Mann-Whitney U-test. Confocal cluster density of total PSD-95, total and synaptic GluA1 and GluA2, and immunoperoxidase staining was analyzed by two-tailed Student's t test. The statistical tests used for each analysis are indicated in the figure legends. A p value of < 0.05 was considered significant. Data are presented as mean ± standard error of the mean (SEM), unless otherwise stated. The a-error was set at 0.05. In all figures p values are indicated as follows: *p < 0.05; **p < 0.01; ***p < 0.001. Tests were done using SigmaPlot 13.0 (Systat, San Jose, CA, USA).
